United States · FDA National Drug Code directory
Dasatinib
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60505-3817_ec5a2f19-c89e-c4cd-c819-a22c585d18b4
- Product NDC
- 60505-3817
- Form
- TABLET, FILM COATED
- Composition / generic term
- Dasatinib
- Labeler
- Apotex Corp.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240903
- Source listing expiry
- 20261231
Source-listed ingredients
- DASATINIB — 140 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (60505-3817-3) · 60505-3817-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →